Stay updated on Pembrolizumab and Itacitinib for NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Itacitinib for NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Itacitinib for NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page shows a revision label updated from v3.5.3 to v3.5.4, indicating a recent update to the page's content or metadata. This reflects a backend or content refresh rather than changes to the study data.
    Difference
    0.1%
    Check dated 2026-05-20T16:50:45.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.5.2 to v3.5.3, indicating a refreshed content version.
    Difference
    0.1%
    Check dated 2026-04-29T09:09:04.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Updated the page footer revision label from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-22T03:23:00.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    The header now shows Revision: v3.5.0, replacing Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-24T05:48:33.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.2 to v3.4.3. There are no visible changes to study details or outcomes.
    Difference
    0.1%
    Check dated 2026-03-10T00:30:17.000Z thumbnail image
  8. Check
    101 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2; no clinical content, eligibility criteria, results, or critical page data were changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-16T15:54:51.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Itacitinib for NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Itacitinib for NSCLC Clinical Trial page.